A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorYan Li
About this trial
24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the European Society of Cardiology (ESC) guideline on ambulatory blood pressure monitoring. Finally, we should promote the clinical application of 24 hour ambulatory blood pressure monitoring to greatly improve the management level of hypertension in China and effectively reduce the risk caused by hypertension in the population.
Information of hypertensive patients with ambulatory blood pressure monitoring was prospectively registered nationwide,and then to investigate whether there was difference in cardiovascular prognosis according to the control of ABP.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-80 years old
Clinical diagnosed hypertension with the use of antihypertensive drugs
A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
Willing to provide information about disease history and blood biochemical test data within 6 months.
Disqualifiers
Without antihypertensive drug use
Hospitalized hypertension patients
Non-compliant patient
Trial population
primary care clinic, and community sample
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Composite end point of major cardiovascular and cerebrovascular events
Composite end point of major cardiovascular and cerebrovascular events
Time frame
From date of enrollment until date of first documented event or date of death from cardiovascular and cerebrovascular events, whichever came first, assessed up to 3 yearsSecondary outcomes
1
The control rate of clinic blood pressure
Time frame
From date of enrollment until study completion,an average of 3 years2
The control rate of 24-hour ambulatory blood pressure
Time frame
From date of enrollment until study completion,an average of 3 years3
the proportion of white-coat uncontrolled hypertension
Time frame
From date of enrollment until study completion,an average of 3 years4
the proportion of masked uncontrolled hypertension
Time frame
From date of enrollment until study completion,an average of 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Yan Li
Lead sponsor
Shanghai Institute of Hypertension
Sponsor institution
Source ClinicalTrials.gov